clinical trials

Exelixis throws in the towel on early-stage liver cancer after final readout shows OS flop
Endpoints
Tue, 03/15/22 - 10:39 am
Exelixis
Cabometyx
liver cancer
clinical trials
Moderna hits the gas as it begins dosing of 2nd HIV vaccine
Fierce Biotech
Mon, 03/14/22 - 11:40 pm
Moderna Therapeutics
MRNA
HIV
vaccines
clinical trials
Long wait for pivotal data on Sanofi's oral SERD ends in failure
Fierce Biotech
Mon, 03/14/22 - 10:32 am
Sanofi
Amcenestrant
Serds
breast cancer
clinical trials
BMS-Nektar's Opdivo combo fails phase 3 in upset to once-largest licensing deal in biotech history
Fierce Biotech
Mon, 03/14/22 - 10:24 am
Bristol Myers Squibb
Opdivo
Nektar Therapeutics
bempegaldesleukin
clinical trials
BridgeBio plots path to market for muscular dystrophy drug after posting phase 2 data
Fierce Biotech
Mon, 03/14/22 - 10:22 am
BridgeBio Pharma
limb-girdle muscular dystrophy
clinical trials
BBP-418
Erasca, Eli Lilly partner for colorectal cancer therapy trial
Pharmaceutical Business Review
Fri, 03/11/22 - 10:37 am
Erasca
Eli Lilly
clinical trials
ERAS-007
colorectal cancer
Venatorx plans new antibiotic filing after phase 3 readout
Pharmaforum
Fri, 03/11/22 - 10:34 am
Venatorx Pharma
antibiotics
clinical trials
antibiotic resistance
Selecta back in phase 1 gene therapy saddle after clinical hold lift, plans to reboot 'expeditiously'
Fierce Biotech
Thu, 03/10/22 - 10:27 pm
Selecta Biosciences
gene therapy
rare disease
methylmalonic acidemia
clinical trials
Venatorx hits goal in antibiotic phase 3, clearing path to FDA
Fierce Biotech
Thu, 03/10/22 - 10:29 am
VenatoRx
antibiotics
clinical trials
FDA
UTIs
Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Bivalent Booster Candidate
Yahoo/Accesswire
Thu, 03/10/22 - 10:25 am
Moderna Therapeutics
COVID-19
vaccines
MRNA
clinical trials
Omicron variant
boosters
bivalent boosters
NuCana's twist on chemo drug Gemzar fails in phase 3 again
Fierce Pharma
Wed, 03/9/22 - 11:17 pm
Nucana
Acelarin
Gemzar
clinical trials
biliary cancer
A trio of amyloid-targeted Alzheimer's drugs will soon see key results, but an analyst predicts only 50-50 odds for one
Endpoints
Wed, 03/9/22 - 11:09 pm
Alzheimer's disease
clinical trials
Roche
Eli Lilly
Biogen
donanemab
lecanemab
gantenerumab
Sanofi, scarred by Roche scrap, hits goal in once-weekly hemophilia A trial and plots race to regulators
Fierce Biotech
Wed, 03/9/22 - 10:54 am
Sanofi
Roche
Sobi
hemophilia A
clinical trials
Pfizer to begin late-stage testing of Covid-19 antiviral for kids
Politico
Wed, 03/9/22 - 10:53 am
Pfizer
antivirals
COVID-19
Paxlovid
pediatric
clinical trials
With lung drug from Pfizer in hand, AN2 tests IPO waters in turbulent market
MedCity News
Tue, 03/8/22 - 10:01 am
AN2 Therapeutics
Okyo Pharma
IPOs
clinical trials
lung disease
dry eye disease
Death in Alpine's Keytruda combo trial triggers clinical hold, raises specter of earlier tragedy
Fierce Biotech
Mon, 03/7/22 - 11:01 pm
Alpine Immune Sciences
davoceticept
Merck
Keytruda
clinical trials
patient deaths
Gilead says breast cancer drug succeeded in key study, but offers few details
BioPharma Dive
Mon, 03/7/22 - 10:52 pm
Gilead Sciences
Trodelvy
clinical trials
M&A
breast cancer
Astellas’ eyes filings for menopause drug fezolinetant after ph3 win
Pharmaforum
Mon, 03/7/22 - 10:07 am
Astellas
menopause
clinical trials
fezolinetant
hot flashes
UK Recovery trial confirms Covid benefit for Olumiant
EP Vantage
Mon, 03/7/22 - 09:55 am
Eli Lilly
clinical trials
COVID-19
olumiant
Roche starts new four-year trial of Alzheimer’s drug gantenerumab
Pharmaforum
Fri, 03/4/22 - 09:48 am
Roche
Alzheimer's disease
clinical trials
gantenerumab

Pages